Related Experiment Video
Updated: Oct 25, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.4K
[FEATURES OF THE COMPLICATED COURSE OF NON-HOSPITAL VIRAL COVID-19 PNEUMONIA]
M Lynnyk1, М Gumeniuk1, I Liskina1
11GU "National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky NA MS of Ukraine ";Ukraine.
Georgian Medical News
|August 8, 2021
Summary
Severe COVID-19 pneumonia can lead to serious lung complications like disappearing lung syndrome. These post-viral changes, including emphysema and vascular issues, require further study for effective treatment.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pathology
Background:
- Community-acquired viral pneumonia caused by COVID-19 can present with severe, complicated courses.
- Patients often require referral from other institutions for advanced treatment of persistent pneumonia.
- Long-term sequelae of COVID-19 pneumonia necessitate detailed clinical and morphological investigation.
Purpose of the Study:
- To document clinical observations of complicated COVID-19 pneumonia.
- To highlight severe complications such as bullous pulmonary emphysema ('disappearing lung syndrome').
- To analyze post-COVID-19 lung changes and their pathological basis.
Main Methods:
- Clinical observation of patients with complicated COVID-19 pneumonia.
- Review of treatment histories from referring medical institutions.
- Morphological study of postoperative materials from patients with post-COVID-19 complications.
Main Results:
- The formation of bullous pulmonary emphysema ('disappearing lung syndrome') was observed as a serious complication.
- Morphological studies revealed an absence of typical chronic inflammation and fibrosis in some cases.
- Persistent productive endarteritis and secondary vascular malformations leading to cysts and emphysema were noted.
Conclusions:
- Complicated COVID-19 pneumonia can result in severe lung conditions like bullous pulmonary emphysema.
- Pathological findings in the post-COVID period may differ from typical inflammatory responses.
- Further research into surgical tactics for COVID-19-associated lung complications is crucial.
More Related Videos
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
534
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534
01:29Pneumonia II: Pathophysiology
1.1K
The pathophysiology of pneumonia involves the following steps:
1.1K
01:28Pneumonia IV: Management
521
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
521
01:30Pneumonia I: Introduction
427
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
427
01:20COPD: Pathogenesis and Clinical Features
765
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
765
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K